Nonhormonal Therapies for Menopausal Vasomotor Symptoms-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nonhormonal Therapies for Menopausal Vasomotor Symptoms

Published:2023-10-03 Issue:13 Volume:330 Page:1278
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Christ Jacob P.¹,Navarro Víctor M.²³,Reed Susan D.⁴

Affiliation:

1. Department of Obstetrics and Gynecology, University of San Francisco, San Francisco, California

2. Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts

3. Harvard Graduate Program in Neuroscience, Boston, Massachusetts

4. Department of Obstetrics and Gynecology, University of Washington School of Medicine, Seattle

Abstract

This JAMA Insights in the Women’s Health series describes the use of fezolinetant and neurokinin B antagonists as nonhormonal therapies for menopausal vasomotor symptoms.

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jama/articlepdf/2809765/jama_christ_2023_it_230014_1696283275.69704.pdf

Reference7 articles.

1. Duration of menopausal vasomotor symptoms over the menopause transition.;Avis;JAMA Intern Med,2015

2. The menopause transition.;Santoro;J Clin Endocrinol Metab,2021

3. Invited review: translating kisspeptin and neurokinin B biology into new therapies for reproductive health.;Mills;J Neuroendocrinol,2022

4. Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1).;Lederman;Lancet,2023

5. Efficacy and safety of fezolinetant in moderate to severe vasomotor symptoms associated with menopause.;Johnson;J Clin Endocrinol Metab,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP